Metraipolis › archive › dc_73f1bb27de9e
An integrative neuropharmacological review of Huntington's disease challenges and the role of novel formulations in addressing pharmacological‒pharmaceutical… — Europe PMC PMID:42181874
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42181874
- DOI
- 10.3389/fphar.2026.1794983
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T15:07:12.994Z
- SHA-256 of the archived text
3dac86c7d419b4cc0b38f5a6a9da91dccc5e58b5ff9286b2afbc6e835a93d8ec- Stable URL of this page
https://metraipolis.com/documento/dc_73f1bb27de9e
How to cite
An integrative neuropharmacological review of Huntington's disease challenges and the role of novel formulations in addressing pharmacological‒pharmaceutical… — Europe PMC PMID:42181874 — Europe PMC (en), https://europepmc.org/article/MED/42181874 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_73f1bb27de9e (Metraipolis archive dc_73f1bb27de9e, sha256 3dac86c7d419b4cc0b38f5a6a9da91dccc5e58b5ff9286b2afbc6e835a93d8ec)
BibTeX
@misc{dc73f1bb27de9e,
title = {An integrative neuropharmacological review of Huntington's disease challenges and the role of novel formulations in addressing pharmacological‒pharmaceutical… — Europe PMC PMID:42181874},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42181874},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_73f1bb27de9e; sha256 3dac86c7d419b4cc0b38f5a6a9da91dccc5e58b5ff9286b2afbc6e835a93d8ec},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42181874. Agents can read the archived copy with the MCP tool read_document.